Morgan Stanley Maintains Healthpeak Properties(DOC.US) With Hold Rating, Maintains Target Price $23.5
Morgan Stanley Maintains Healthpeak Properties(DOC.US) With Hold Rating, Maintains Target Price $23.5
Healthpeak Properties Analyst Ratings
Wells Fargo Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $23
Healthpeak Properties (DOC) Receives a Hold From Wells Fargo
JPMorgan Adjusts Price Target on Healthpeak Properties to $24 From $21, Maintains Neutral Rating
J.P. Morgan Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $24
Healthpeak Properties Is Maintained at Outperform by Evercore ISI Group
Healthpeak Properties Analyst Ratings
Evercore Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $26
Scotiabank Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $24
Scotiabank Reaffirms Their Buy Rating on Healthpeak Properties (DOC)
Scotiabank Adjusts Healthpeak Properties Price Target to $24 From $23
Healthpeak Properties Is Maintained at Outperform by Evercore ISI Group
Healthpeak Properties Analyst Ratings
Evercore Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $25
Morgan Stanley Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $23.5
Healthpeak Properties Hold Rating: Balancing Merger Benefits Against Lab Space Market Risks
Healthpeak Properties (DOC) Gets a Hold From Wells Fargo
Citigroup Adjusts Price Target on Healthpeak Properties to $22 From $20, Maintains Neutral Rating